Stay updated on Inhaled Aviptadil for COVID-19 in High-Risk: Clinical Trial
Sign up to get notified when there's something new on the Inhaled Aviptadil for COVID-19 in High-Risk: Clinical Trial page.

Latest updates to the Inhaled Aviptadil for COVID-19 in High-Risk: Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page revision tag was updated from v3.5.3 to v3.5.4, indicating a CMS/backend update. There is no apparent change to the study content or data presented on the page.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedUpdates the ClinicalTrials.gov page revision/version from **v3.5.2** to **v3.5.3**, reflecting a site release change rather than a change to the study details.SummaryDifference0.1%

- Check43 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check72 days agoChange DetectedA new revision entry 'Revision: v3.5.0' appears and the previous 'Revision: v3.4.3' entry is removed.SummaryDifference0.1%

- Check79 days agoChange DetectedThe page metadata now shows Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.1%

- Check107 days agoChange DetectedAdded Revision: v3.4.2 and removed the older notices (including the lapse in government funding notice and Revision: v3.4.1). These are administrative updates and do not affect the study's content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Inhaled Aviptadil for COVID-19 in High-Risk: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhaled Aviptadil for COVID-19 in High-Risk: Clinical Trial page.